Key result
High loop diuretic doses show no independent link to 1-year cardiovascular death or rehospitalization.
Why the study?
Loop diuretics are essential for congestion in acute heart failure, but concerns exist regarding their dosing and administration.
Does high loop diuretic dosage increase the composite of cardiovascular rehospitalization or death in patients with acute heart failure?
Cohort (n=370)
No
Does high loop diuretic dosage increase the composite of cardiovascular rehospitalization or death in patients with acute heart failure?
Answers are grounded in this paper and cite their sources.
High loop diuretic doses in acute heart failure are associated with worse outcomes due to underlying disease severity rather than direct harm, and do not negatively affect kidney function.
Background Loop diuretics are essential for managing congestion in acute heart failure (AHF) patients, but concerns exist about their dosing and administration. This study aims to explore the relationship between aggressive diuretic treatment and clinical outcomes in AHF patients. Methods We randomly selected 370 AHF patients from admissions at Maastricht University Medical Center between January 2011 and March 2017. Patients were divided into four quartiles based on diuretic doses administrated during index hospitalization. The primary endpoint was a composite of cardiovascular (CV) rehospitalization or death at 1 year. Results 42.4% of patients experimented the primary outcome The composite endpoint rates were 35.4%, 41.6%, 38.5%, and 54.9%, respectively, from lowest to highest dose quartiles ( p = 0.033). In univariate analysis, the outcome was significantly lower in the first three quartiles as compared to the fourth quartile. One-year CV mortality was 9.1%, 10.1%, 20.9% and 27.2%, respectively ( p = 0.002). After adjusting for confounders, the association between loop diuretic dosage disappeared for both the primary outcome and one-year CV mortality. Most secondary outcomes and endpoints at 3 months, including worsening renal function, showed no significant differences between groups, while hypokaliemia occurrence, length of hospital stay and weight loss at index admission were higher in the fourth quartile compared to the first one. Conclusions High loop diuretic doses are associated with poor outcomes in AHF patients, reflecting disease severity rather than harm from aggressive diuretic use. Furthermore, high diuretic doses do not seem to negatively affect kidney function.
No takes yet. Share an insight, caveat, or question.
Meani et al. (2023) conducted a cohort in Acute heart failure (n=370). High-dose loop diuretics vs. Lower-dose loop diuretics (≤175 mg/day furosemide equivalents) was evaluated on Composite of cardiovascular mortality or cardiovascular rehospitalization at 1 year (HR 1.62, 95% CI 1.05-2.27, p=0.005). High loop diuretic doses increased the unadjusted risk of cardiovascular death or rehospitalization at 1 year, but this association disappeared after adjusting for confounders.
Synapse has enriched 10 related papers. Consider them for comparative context: